Primary Cryoablation Nadir Prostate Specific Antigen and Biochemical Failure

Journal of Urology

Volumn 182, Issue 3, 2009, Pages 931-937

  Levy, David A ^a   Pisters, Louis L ^b   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cryosurgery; prostate specific antigen; prostatic neoplasms; treatment outcome

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRYOABLATION; DISEASE FREE SURVIVAL; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CRYOSURGERY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TREATMENT FAILURE;

EID: 68149157350     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.05.041     Document Type: Article

References (14)

1. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965
2. Cookson M.S., Aus G., Burnett A.L., et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177 (2007) 540
3. Babaian R.J., Donnelly B., Bahn D., et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 180 (2008) 1993
4. Long J.P., Bahn D., Lee F., et al. Five year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 57 (2001) 518
5. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37 (1997) 1035
6. Bahn D., Lee F., Badalament R., et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60 (2002) 3
7. Donnelly B.J., Saliken J.C., Ernst D.S., et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 60 (2002) 645
8. Ellis D.A. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 60 (2002) 34
9. Jones J.S., Rewcastle J.C., Donnelly B.J., et al. Whole gland primary prostate cryoablation: initial results from the Cryo On-Line Data Registry. J Urol 180 (2008) 554
10. Cohen J.K., Miller Jr. R.J., Ahmed S., et al. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 71 (2008) 515
11. D'Amico A.V., Moul J., Carroll P.R., et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate specific antigen era. J Clin Oncol 21 (2003) 2163
12. Shinohara K., Rhee B., Presti J.C., et al. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol 158 (1997) 2206
13. Benoit R.M., Cohen J.K., and Miller Jr. R.J. Cryosurgery for prostate cancer: new technology and indications. Curr Urol Rep 1 (2000) 41
14. Ellis D.S., Manny Jr. T.B., and Rewcastle J.C. Cryoablation as a primary treatment for localized prostate cancer followed by early penile rehabilitation. Urology 69 (2007) 306